These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12076179)

  • 1. Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams.
    Carbon C; Isturiz R
    Drugs; 2002; 62(9):1289-94. PubMed ID: 12076179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.
    Sunakawa K; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():7. PubMed ID: 17697316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
    Doern GV
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.
    Van Bambeke F; Reinert RR; Appelbaum PC; Tulkens PM; Peetermans WE
    Drugs; 2007; 67(16):2355-82. PubMed ID: 17983256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics.
    Opatowski L; Mandel J; Varon E; Boëlle PY; Temime L; Guillemot D
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2330-7. PubMed ID: 20231396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pneumococcal antibiotic resistance].
    Moreillon P; Wenger A; Caldelari I
    Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms].
    Sidorenko SV
    Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antimicrobial resistance profile of Streptococcus pneumoniae.
    Reinert RR
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.
    Schrag SJ; Beall B; Dowell SF
    Clin Microbiol Rev; 2000 Oct; 13(4):588-601. PubMed ID: 11023959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004).
    Cantón R; Unal S; Farrell DJ
    Int J Antimicrob Agents; 2007 Dec; 30(6):546-50. PubMed ID: 17931834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?
    Nuermberger EL; Bishai WR
    Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin.
    Felmingham D
    J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance].
    Bédos JP; Bruneel F
    Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.